The State. A public institution holds it under the Charter. A national-majority committee decides every use. LydiaRx takes no ownership of samples or data, during the pilot or after it.
Nothing we build depends on us staying. The laboratory, equipment and data environment are installed in the institution and offered to it; the data never left; every governance document is published; the hosting agreement provides for continuity of the platform.
Yes, by bringing their question to it. They receive governed, non-identifying results with a provenance certificate. Never a copy. The committee can refuse any request. The ledger records every one.
The pilot's agreements set out LydiaRx's role as operator of the environment and the research gateway, on terms the Government approves. Beyond that, nothing commits the Government to any further stage. The centre, the data, the team and the published standard remain; what follows is decided on measured national figures, not a partner's promises.
The State. The environment runs on infrastructure the Government controls, inside the country; identities are held by the sponsoring institution; access is granted by a national-majority committee, never by LydiaRx; and every action is on a ledger the State verifies without us. Our staff work under the institution's authority and the Charter, national staff run the centre from the first year, and nothing is designed to need us in the room.
Check the people, not the letterhead. The individuals on our people page built the programmes a national genome effort is modelled on; every one can be verified. We carry the pilot's financing risk; a pilot is small enough to be safe and real enough to judge.
A pharmaceutical company asks whether a variant common in the population changes the response to a widely prescribed medicine. What happens:
Ask it. A briefing is with a founder.